Diagnosis and treatment of chronic T-lymphocytic leukemia in a spotted hyena (Crocuta crocuta)

J Zoo Wildl Med. 2007 Sep;38(3):488-91. doi: 10.1638/1042-7260(2007)38[488:DATOCT]2.0.CO;2.

Abstract

Physical examination of an asymptomatic 20-yr-old intact female spotted hyena (Crocuta crocuta) revealed a midabdominal mass. A complete blood count (CBC) revealed peripheral lymphocytosis. Abdominal ultrasonography and laparoscopy confirmed severe splenomegaly. Cytologic examination of a bone-marrow core and histologic examination of spleen and liver biopsy samples revealed neoplastic small lymphocytes. Immunohistochemical staining of liver and spleen samples with the use of leukocyte-specific monoclonal antibodies showed that the neoplastic lymphocytes were immunoreactive to T-lymphocyte CD3 receptor and immunonegative to B-lymphocyte CD79a receptor. The morphology and distribution of neoplastic T-lymphocytes within the spleen, liver, peripheral blood, and bone marrow was most consistent with chronic T-lymphocytic leukemia. Treatment with chlorambucil and prednisone effectively decreased the lymphocyte count, but was associated with thrombocytopenia, which resolved after chlorambucil treatment was temporarily discontinued. Chemotherapy was resumed with a single dose of L-asparaginase, followed by a lower dosage of chlorambucil and continued prednisone. Two years after initial diagnosis, the hyena developed a hemoabdomen and was euthanized. Neoplastic T-lymphocytes were present in spleen, liver, visceral and peripheral lymph nodes, lungs, heart, kidney, adrenal glands, mesentery, intestines, pancreas, brain, and bone marrow.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Fatal Outcome
  • Female
  • Hyaenidae*
  • Leukemia, T-Cell / diagnosis
  • Leukemia, T-Cell / drug therapy
  • Leukemia, T-Cell / pathology
  • Leukemia, T-Cell / veterinary*
  • Neoplasm Metastasis
  • Treatment Outcome

Substances

  • Antineoplastic Agents